๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Paradoxical enhancement of opioid antinociception by both a dopamine (D2) agonist and antagonist

โœ Scribed by Armstrong, R.A.; Sewell, R.D.E.; Spencer, P.S.J.

Book ID
121979227
Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
111 KB
Volume
41
Category
Article
ISSN
0304-3959

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Attenuation of the locomotor-sensitizing
Attenuation of the locomotor-sensitizing effects of the D2 dopamine agonist bromocriptine by either the D1 antagonist SCH 23390 or the D2 antagonist raclopride
โœ Roy A. Wise; William A. Carlezon Jr. ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 525 KB

Injections of the selective D, dopamine agonist bromocriptine (5.0 mg/ kg, IP) produced progressively stronger locomotion over 10 days of repeated testing. Concurrent treatment with either the D, antagonist SCH 23390 (0.01 or 0.1 mg/kg, IP) or the D, antagonist raclopride (0.1 or 1.0 mg/kg, IP) supp